AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 1 filers reported holding AYALA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,001 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 542,977 | $5,533,000 | 1.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,364 | $238,000 | 0.11% |
| Redmile Group, LLC | 667,816 | $6,805,000 | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31,962 | $326,000 | 0.01% |
| Marshall Wace North America L.P. | 49,266 | $502,000 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 704,363 | $7,178,000 | 0.00% |
| Chevy Chase Trust Holdings, LLC | 15,000 | $153,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 470 | $4,000 | 0.00% |
| UBS Group AG | 5,509 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |